Risk Control for Transferors under Earn-out Mechanisms

文章摘要 本文聚焦中国上市公司并购交易中Earn-out(盈利能力支付计划)机制下转让方的风险控制问题。文章指出,传统业绩补偿(Earn-back)机制常因承诺方违约、诉讼执行难等原因导致上市公司利益受损,因此近年来越来越多交易采用Earn-out安排,即分期支付对价以绑定标的公司未来业绩。核心法律要点包括:转让方需明确Earn-out条款的法律性质(属于价款调整而非独立担保),关注业绩指标的定义与计算口径,防范收购方利用控制权干预标的公司经营导致业绩不达标;实务操作建议包括:在协议中细化业绩考核标准、排除不可抗力及收购方不当干预情形、约定加速到期条款、设置担保措施(如股权质押或第三方保证)、并明确争议解决机制(如仲裁或诉讼地选择);关键判断是,转让方应通过合同条款将Earn-out风险从“对赌”性质转换为“递延付款”性质,以降低违约和执行风险,同时建议在交易文件中对标的公司治理权、财务合规义务及审计程如求具体程序,确保业绩数据公正性。文章还提示,中国法律框架下,法院对业绩补偿条款的调整权较大,转让方需重视协议措辞的合理性与可执行性。

In mergers and acquisitions (M&A) involving Chinese listed companies, Earn-back mechanisms are often standard practice. However, some portfolio companies fail to meet performance targets due to subjective or objective reasons[1]. When compensation obligations arise, promisors may default, forcing listed companies to resort to litigation or arbitration to enforce commitments[2]. Even after prevailing in court, recovery may prove challenging[3]. Consequently, listed companies have increasingly adopted Earnout mechanisms in recent years[4]. Indeed, Earn-outs are a common transactional arrangement in international M&A. 

 

I. Definition of Earn-out Mechanism

An Earn-out mechanism is employed when parties to an M&A transaction cannot agree on the valuation of target assets or entities. It provides that the Acquirer will pay additional consideration if the target achieves predetermined objectives (the "Target Metrics") within a specified post-closing period. Payment is contingent solely on achieving these metrics; if unmet, no further payment is due. Thus, it constitutes contingent consideration. 

Similar to Earn-back mechanisms, Earnouts are typically used in transactions where valuation disagreements arise from information asymmetry or divergent views on the portfolio companies’ future profitability. To bridge this gap, the Transferor commits to future performance under an Earn-back structure, compensating the Acquirer if targets are missed. Conversely, under an Earnout, the Acquirer pays an initial sum reflecting its valuation at closing, with additional consideration payable only if the target achieves metrics advocated by the transferor. This balances the transferor’s interests. While financial metrics (e.g., profitability) are common, nonfinancial targets, such as R&D milestones in pharmaceutical acquisitions, may also serve as Earn-out criteria. 

Notably, Earn-outs afford greater control to Acquirers compared to Earn-back structures. Thus, transferors must carefully consider risk mitigation strategies under such mechanisms. 

 

II. Earn-out Provisions 

 

Though prevalent in cross-border M&A, Earn-out clauses are among the most dispute-prone contractual terms. Disputes typically center on: (a) whether Target Metrics were achieved, and (b) the causes of any failure. Consequently, the drafting of Earn-out terms mandates meticulous attention to: (i) determinacy of performance targets; (ii) coherence of contractual logic; (iii) mitigation protocols for achievement barriers.

 

1. Precisely definition of Financial Metrics 

Target Metrics may be financial (e.g., net profit, EBIT/EBITDA, revenue growth over 2–3 years) or nonfinancial. Despite their quantitative nature, financial metrics are susceptible to interpretive conflicts arising from accounting methodologies. In one cross-border deal we advised on, the parties used a three-year gross profit compound annual growth rate (CAGR) to determine contingent payments. To preempt disputes, we: 

-       Explicitly defined gross profit, base gross profit, and gross profit CAGR; 

-       Detailed calculation methodologies (including relevant accounting line items) and pricing formulas via tables and notes; 

-       Instituted an independent expert resolution process for pricing disputes. 

In another transaction involving EBITDA CAGR targets, bespoke adjustments (e.g., excluding government subsidies, rent modifications) were incorporated. 

 

2. Objective, Operable, and Logically Sound Non-financial Metrics

Non-financial metrics may include KPIs, production/sales volumes, market share, daily active users (DAU), R&D milestones, key contract executions, product launches, or clinical trial phases. Metric based targets should emulate the precision applied to financial metrics. Milestone based targets require multidimensional definitions to ensure objectivity and operability. Where multiple milestones exist, logical sequencing must avoid ambiguity. 

In a share transfer dispute we handled, the agreement included both net profit targets and phased DAU metrics. While cumulative DAU and net profit were achieved, one interim DAU phase was missed. The Transferor argued for aggregate assessment; the Acquirer insisted on phased compliance. The dispute arose from insufficient logical integration of the metrics. 

In another deal involving a lithium iron phosphate cathode producer, the Transferor claimed ongoing negotiations with CATL for a long-term supply agreement. Given uncertainty, the Acquirer proposed tying a lumpsum payment to the execution of such an agreement. In drafting the Earn-out provisions, we established the following conditions from the Acquirer’s perspective for the long-term supply agreement: required duration, minimum annual sales volume, minimum annual sales value as well as operational performance commitments. While the Transferor negotiated expansions to product categories and permitted buyer scope. Such considerations culminate in a definitive agreement between the Parties.

 

3. Critical for Target Achievement: Operational Control 

Acquirers often retain the transferor’s management or R&D team during the Earn-out period to ensure transition stability. However, if the management rights of the parties are not clearly delineated in the M&A agreement, disputes will inevitably arise.

In a share transfer dispute, the parties verbally agreed that the Transferor (Mr. Xu) would remain as General Manager (GM) for three years post-closing. The agreement, however, merely appointed him to the five-member board, which retained GM hiring/firing authority. Post-closing, irreconcilable conflicts between Xu and the board-chair (appointed by the Acquirer) led to Xu’s removal and termination. Deprived of operational control, Xu failed to meet the Earn-out targets, finally the Acquirer withheld 40% of the consideration. 

While the Acquirer’s actions were legally defensible under corporate law, they undermined the transferor’s interests. Such cases, common under Earn-back mechanisms[5] highlight the need to explicitly define operational rights and remedies for interference. 

In a cross-border deal we advised, the Acquirer proposed standard corporate governance (shareholder supremacy). Representing the transferor, we: 

-       Exhaustively enumerated shareholder and board powers; 

-       Reserved all residual authority to the GM (to be appointed by the transferor); 

-       Stipulated that Acquirer interference with GM authority would trigger deemed Earn-out achievement and full payment; 

-       Negotiated liquidated damages for specified interference (subject to dispute resolution). 

This balanced solution accounted for the parties’ bargaining power and operational priorities. Where Acquirers demand operational control, defining both metrics and management boundaries becomes paramount. 

 

4. Other Factors Impacting Target Achievement 

Any variable affecting Target Metrics warrants quantification. For instance, during negotiations for an 2018 cross-border deal amid escalating Sino-US trade tensions, we analyzed potential tariff impacts and incorporated tiered adjustment mechanisms for each tariff scenario into the Earn-out terms. 

 

Conclusion 

Earn-outs are increasingly prevalent in both cross-border and domestic M&A. It is suggested that transferors should formulate realistic projections of target profitability,  collaborate on balanced valuations, as well as diligently draft and perform agreements with legal counsel. These steps are essential to achieve Target Metrics and secure expected returns. 

 

 

 About the Author    

Chambers (Chunbao) Yang, a Senior Partner, Head of the Capital Markets Department, and Director of the State-Owned Fund Research Center at Dacheng Law Offices LLP (Shanghai). He also serves as the Leader of the Private Equity and Investment Funds Practice Group for Dacheng China and is a member of the Shanghai Foreign-Related Legal Talents Pool. He holds a Bachelor of Laws from Fudan University (1992), a Master of Laws from the University of Technology Sydney (2001), and a Master of Laws from East China University of Political Science and Law (2001).

 

With 30 years of legal practice, Mr. Yang has long been engaged in legal services related to private equity funds, investment and financing, and mergers and acquisitions, covering industries such as large finance, large health, real estate and infrastructure, TMT (Technology, Media, and Telecommunications), exhibition industry, and manufacturing. Since 2004, he has been repeatedly listed in The Legal 500's rankings for "Private Equity" and "Corporate and Commercial" sectors, and has been specially recommended or commented on by Asia Law Profiles on multiple occasions. Since 2016, he has been continuously selected into the "Top 100 PRC Elite Lawyer" by China Business Law Journal. He was awarded the title of "China Corporate Law Expert of the Year" at the Leaders in Law - 2021 Global Awards, and has been consistently listed in the Recommended Directory of Excellent Lawyers Recommended by General Counsel of Well-Known Chinese Enterprises. He has also won awards such as "China TMT Lawyer of the Year" and "China M&A Lawyer of the Year" from Lawyer Monthly and Finance Monthly on multiple occasions.

 

Mr. Yang is qualified to serve as an independent director of listed companies. He is a part-time professor at the School of Law of East China University of Science and Technology, a practical tutor at the Law School of Fudan University, a part-time graduate tutor at East China University of Political Science and Law, a lecturer for the Private Equity CEO Program at Shanghai Jiao Tong University, and a lecturer for the Transnational Operation Talent Training Program of the Shanghai Municipal Commission of Commerce. He has published 16 monographs, including Practical Operations for Risk Prevention and Control in Private Equity Investment Funds, Practical Operations and Case Analysis of Enterprise-Wide Legal Risk Prevention and Control, and Winning Capital 2: A Complete Operation Guide to Corporate Investment and Financing Modes and Processes.

 

Mr. Yang's practice areas include: corporate law, investment, mergers and acquisitions, and private equity funds, capital markets, TMT, real estate and construction engineering, as well as dispute resolution in the aforementioned fields.

 

Email: chambers.yang@dentons.cn 

 Tel: +86 13901826830 

 

Footnotes:

[1]: See 24 Listed Companies’ M&A Targets Defaulted on Earn-back Obligations; Litigation Ensues, Xinhua News Agency (Dec. 14, 2017). 

[2]: E.g., DunAn Environment announced on Aug. 28, 2019, that it filed a lawsuit with Shaoxing Intermediate People’s Court against the target’s former controller Qiu Shaojie for compensation. 

[3]: Hongda Mining announced a favorable court judgment on June 19, 2019, but noted that enforcement against shares held by the defaulting shareholder faced challenges due to third-party liens. 

[4]: E.g., Shanghai Shenkai’s acquisition of 60% equity in Hangzhou Fenghe, with Earnout payments tied to net profit. 

[5]: See M&A disputes involving listed companies such as Shinva Medical and Blue Focus. 

杨春宝一级律师简介

杨春宝一级律师,大成上海高级合伙人、资本市场部主任、国资基金研究中心主任,大成中国区私募基金专业带头人、科技与文化法律研究中心联合牵头人。执业30余年,长期从事私募基金、投融资、并购重组法律服务,尤其对对赌研究颇深且具有非常丰富的实战经验,并专注于金融机构股权投资业务。2004年起多次入选The Legal 500"私募基金"和"公司与商业"等境内外各类律师榜单,代理的中国法院首例适用外国法律审理外国公司的董事损害小股东权益纠纷案入选上海高院发布的《上海法院域外法查明典型案例》和威科先行"要案头条"。具有上市公司独立董事任职资格,系多家知名高校的兼职教授或兼职研究生导师及上海市商务委跨国经营人才培训班讲师。出版《私募股权投资基金风险防控操作实务》等16本投融资法律专著。了解更多

常见法律问题

在Earn-out机制中,转让方(卖方)如何控制因业绩承诺不达标而引发的补偿风险?

核心观点:转让方应通过事前合同设计、事中履约管理和事后争议解决三个层面系统控制earn-out机制下的补偿风险。法律依据:《上市公司重大资产重组管理办法》第三十五条要求交易对方应当与上市公司就实际盈利数不足预测数的情况签订明确可行的补偿协议;《民法典》第五百八十五条允许约定违约金调整,但过高部分可请求法院酌减。实务建议:第一,在谈判阶段,转让方应争取将earn-out支付与业绩达标标准设计为阶梯式或部分挂钩,避免全部对价均与业绩绑定;第二,针对不可抗力或行业政策变化引发的业绩未达标,应在合同中明确豁免条款,引用不可抗力制度(《民法典》第一百八十条);第三,若已发生补偿义务,转让方可主动与上市公司协商分期支付并增加担保替代一次性现金赔付;第四,若进入诉讼程序,可依据《最高人民法院关于适用〈中华人民共和国民法典〉合同编通则部分司法解释》第三十四条主张违约金过高进行调整,并提交第三方审计报告证明业绩未达标的非主观因素。

如果上市公司作为受让方在业绩补偿争议中提起诉讼,转让方有哪些抗辩要点与反制策略?

核心观点:转让方可从对赌目标合理性、履行障碍及损失计算三方面进行抗辩。法律依据:《最高人民法院关于人民法院审理借贷案件适用法律若干问题的规定》虽非直接适用,但可参照公平原则(《民法典》第六条);《上市公司重大资产重组管理办法》第35条虽要求补偿协议,但未禁止对等抗辩。实务建议:1. 主张不可抗力或情势变更(《民法典》第五百三十三条),若客观政策变化导致业绩不达标,可请求法院调整或解除合同;2. 举证受让方存在不当干预,例如要求转让方参与日常经营决策或输送资源未到位,共同导致业绩下滑,此时可依据《民法典》第五百九十二条过失相抵原则减轻责任;3. 针对受让方未按约提供约定资源(如技术授权、客户渠道)的违约行为,转让方可提出反诉,主张先履行抗辩权(《民法典》第五百二十六条);4. 程序上,转让方可对评估报告或业绩审计报告的资质与准确性提出异议,必要时候申请精神鉴定与补充审计。核心策略在于将单一赔偿纠纷转化为双向违约谈判,争取和解或降低赔偿额。

以上内容仅供参考,不构成法律意见。如需专业法律服务,请联系杨春宝一级律师:chambers.yang@dentons.cn

  • 本站声明:本站所载之法律论文、法律评论、案例、法律咨询等,除非另有注明,著作权人均为站长杨春宝高级律师本人。欢迎其他网站链接,但是,未经书面许可,不得擅自摘编、转载。引用及经许可转载时均应注明作者和出处"法律桥",并链接本站。本站网址:http://www.LawBridge.org。
  •  
  •         本站所有内容(包括法律咨询、法律法规)仅供参考,不构成法律意见,本站不对资料的完整性和时效性负责。您在处理具体法律事务时,请洽询有资质的律师。本站将努力为广大网友提供更好的服务,但不对本站提供的任何免费服务作出正式的承诺。本站所载投稿文章,其言论不代表本站观点,如需使用,请与原作者联系,版权归原作者所有。